Article
Clinical and Genetic Spectrum of ACO2-Linked Dominant Optic Atrophy.
JAMA ophthalmology - 1 May 2026
Beaulieu Cléis, Bouzidi Aymane, Desquiret-Dumas Valérie, Dieu Xavier, Makam Rahul, Jurkute Neringa, Vignal Catherine, Philibert Manon, Odent Sylvie, Zanlonghi Xavier, Latypov Marie, Debourdeau Eloi, Bocquet Béatrice, Yahia Raihane, Pons Linda, Villard Frédéric Pollet, Jeanjean Luc, Verrecchia Sarah, Froment Caroline, Engel Camille, Poirsier Céline, Arndt Carl, Dollfus Hélène, Gohier Philippe, Charif Majida, Ferré Marc, Prunier-Mirebeau Delphine, Meunier Isabelle, Yu-Wai-Man Patrick, Amati-Bonneau Patrizia, Lenaers Guy, Smirnov Vasily
Abstract excerpt
Importance: Aconitase 2 (ACO2) gene variants are one of the most frequent causes of dominant optic atrophy (DOA). However, the associated phenotypes and genotypes still lack proper characterization. Objective: To characterize the clinical and genetic spectrum of ACO2-related DOA and evaluate genotype-phenotype correlations. Design, Setting, and Participants: This was a retrospective case series to describe the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
